13F HOLDINGS REPORT
Lynx1 Capital Management LP
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0001892688-23-000023
Total Value
$115.6M
Positions
13
Other Managers
1
Confidential Omitted
No
Holdings (13)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CABALETTA BIO INC | CABA | 2,825,976 | $26.1M | 22.61% |
| 2 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 3,126,173 | $23.0M | 19.87% |
| 3 | MERUS N V | N5749R100 | 854,591 | $13.2M | 11.43% |
| 4 | KINNATE BIOPHARMA INC | 49705R105 | 1,998,417 | $12.2M | 10.54% |
| 5 | CYMABAY THERAPEUTICS INC | 23257D103 | 1,653,495 | $10.4M | 8.97% |
| 6 | BELLUS HEALTH INC NEW | 07987C204 | 1,093,900 | $9.0M | 7.78% |
| 7 | PIERIS PHARMACEUTICALS INC | 720795103 | 5,628,585 | $5.9M | 5.06% |
| 8 | PARDES BIOSCIENCES INC | 69945Q105 | 3,003,102 | $5.1M | 4.39% |
| 9 | PASSAGE BIO INC | PASG | 3,355,917 | $4.6M | 4.00% |
| 10 | THESEUS PHARMACEUTICALS INC | 88369M101 | 784,158 | $3.9M | 3.38% |
| 11 | NEOLEUKIN THERAPEUTICS INC | 64049K104 | 2,291,133 | $1.2M | 1.01% |
| 12 | AADI BIOSCIENCE INC | WHWK | 64,739 | $830,601 | 0.72% |
| 13 | PHARVARIS N V | PHVS | 25,325 | $284,906 | 0.25% |